Financials
Financial year 2025
Sightera Biosciences from Heist-op-den-Berg, company number BE1018457141, closed financial year 2025 with a result of € 41,452 after tax. For that financial year Sightera Biosciences recorded a gross margin of € 42,079 and equity of € 47,452. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 4, 2026.
€ 47,452
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 41,452
Profit after tax over the fiscal year.
€ 42,658
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 41,452.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 15,385
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to Sightera Biosciences?
What happened at Sightera Biosciences in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 41,452. Source: NBB ↗
- New establishment in Heist-op-den-Berg. KBO
- Maxim Le Compte became a director. NBB
- Lars Vanlommel became a director. NBB
- Hendrik Vercammen became a director. NBB
- Start of the company according to the CBE. KBO
A new publication or filing at Sightera Biosciences? We notify you, reason included.
Follow Sightera BiosciencesDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Sightera Biosciences are Maxim Le Compte, Lars Vanlommel and Hendrik Vercammen.
Directors
According to the 2025 annual accounts
Maxim Le Compte
Director
since 2025
Lars Vanlommel
Director
since 2025
Hendrik Vercammen
Director
since 2025
Establishments
Establishment units
Physical locations of this company
Wiekevorst-Dorp(WIE) 19
2222 Heist-op-den-Berg
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1018.457.141
- VAT number
- BE 1018.457.141
- Registered office
- Wiekevorst-Dorp(WIE) 19, 2222 Heist-op-den-Berg
- Names & denominations
- Sightera Biosciences
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 January 2025
- Peppol
- Active · Active since 25 Aug 2025
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied